CSI Market
Sign In | Register

Opus Genetics Inc (IRD) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access IRD Annual Balance Sheets →
Tracking balance sheet results across Opus Genetics Inc to Mar 31 2025 helps illustrate how Mar 31 2026's financial position has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent59.96
Short-term Investments, Total0.00
Cash & Short-term Investments59.00
Accounts receivable1.73
Other Current Assets0.98
Prepaid Expense And Other Assets Current3.93
Total Current Assets66.60
Equipment/Property/Plant Net0.19
Other Assets, Noncurrent0.00
Contract Assets And Unbilled Receivables Current0.98
Total Assets66.79
Liabilities
Accounts Payable, Current AC4.42
Accrued Liabilities And Other Liabilities4.92
Derivative Liability, Current DE0.00
Other Liabilities, Current0.00
Total Current Liabilities9.34
Long-term debt1.20
Total Long-term Debt1.20
Derivative Liability, Noncurrent DE77.35
Other liabilities, Noncurrent0.00
Total Liabilities87.89
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock208.28
Retained Earnings / Accumulated Deficit-254.12
Other Equity-24.74
Common Stockholder's Equity-70.57
Non-controlling interests & other24.74
Total Stockholder's Equity-45.84
Liabilities & Stockholder's Equity66.79
4 historic quarters locked

Sign in to unlock the full Opus Genetics Inc balance sheet history.

Sign In Create Free Account

About Opus Genetics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 6, 2026
  • Source: ird-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-054381

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.